ArticleThe Journal of biological chemistry2026
Enhanced SIRT3 activity potentiates germinal center epigenetic modulation through α-ketoglutarate.
Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Germinal center (GC) B cells depend on sustained epigenetic modulation to maintain transcriptional identity and support affinity maturation; however, whether mitochondrial metabolism directly enhances this chromatin state remains unclear. Here, we show that enhanced SIRT3 activity promotes glutamine-derived α-ketoglutarate (αKG) accumulation and is associated with reduced H3K27me3 enrichment at the Bcl6 locus. Using SIRT3 K223R gain-of-function mice, metabolomic profiling, and stable isotope tracing, we show that SIRT3 activation increases glutamine-derived αKG accumulation without a uniform increase in downstream tricarboxylic acid (TCA) cycle labeling. Elevated αKG was associated with reduced H3K27me3 at tested Bcl6 regulatory regions, reinforced BCL6 and AID expression, sustained B cell proliferation, and qualitatively enhanced antibody affinity maturation. Glutamine supplementation partially phenocopied these effects, whereas inhibition of glutamine metabolism attenuated them. Importantly, sustained activation of this metabolic-epigenetic axis was associated with enhanced GC expansion accompanied by increased autoantibody levels and renal IgG deposition in a pristane-induced lupus model. Collectively, our findings indicate that enhanced SIRT3 activity potentiates a glutamine-αKG-chromatin axis that links mitochondrial glutamine metabolism to germinal center epigenetic modulation and humoral immune output.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.